Mycobacterium chimaera as an Underestimated Cause of NTM Lung Diseases in Patients Hospitalized in Pulmonary Wards
, , , und | 17. Sept. 2021
Über diesen Artikel
Article Category: original-paper
Online veröffentlicht: 17. Sept. 2021
Seitenbereich: 315 - 320
Eingereicht: 31. März 2021
Akzeptiert: 08. Juli 2021
DOI: https://doi.org/10.33073/pjm-2021-028
Schlüsselwörter
© 2021 Anna T. Zabost et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Fig. 1.
Pathogenicity of isolated M. chimaera strains depending on sex, age, and concomitant pulmonary disease.
| NTMLD | Colonization | Total | ||
|---|---|---|---|---|
| Sex | ||||
| Men | 8 (50) | 8 (50) | 16(100) | |
| Women | 8 (57) | 6(43) | 14(100) | 0,86 |
| Age | ||||
| Years (mean+/-SD) | 58,3 (16,77) | 62,1 (12,86) | 60,1 (15,19) | 0,72 |
| Diagnosis | ||||
| Previous tuberculosis | 5 (83) | 1 (17) | 6 (100) | |
| COPD | 3 (38) | 5 (62) | 8 (100) | |
| Cystic fibrosis | 2(100) | 0 | 2 (100) | |
| Interstitial lung diseases | 2 (40) | 3 (60) | 5 (100) | |
| Post-inflammatory lung fibrosis | 0 | 3 (100) | 3 (100) | |
| Bronchiectasis | 4(100) | 0 | 4(100) | |
| Neoplastic diseases | 1 (50) | 1 (50) | 2 (100) | |
| Diabetes mellitus | 1 (50) | 1 (50) | 2 (100) | |
| Others | 0 | 4 (100) | 4 (100) | |
| No concomitant disease | 2(100) | 0 | 2 (100) | |
Clinical characteristics of patients with positive M. chimaera isolates.
| Concomitant diseases | Number (%) of patients with a given diagnosis | ||
|---|---|---|---|
| Men | Women | Total | |
| COPD | 7 (44) | 1 (7) | 8 (27) |
| Previous tuberculosis | 5 (31) | 1 (7) | 6 (20) |
| Interstitial lung disease | 5 (31) | 0 | 5 (17) |
| Cystic fibrosis | 0 | 2 (14) | 2 (7) |
| Post-inflammatory lung fibrosis | 1 (6) | 2 (14) | 3 (10) |
| Bronchiectasis | 1 (6) | 3 (21) | 4 (13) |
| Neoplastic disease | 2 (13) | 0 | 2 (7) |
| Diabetes mellitus | 1 (6) | 1 (7) | 2 (7) |
| Others | 0 | 4 (21) | 4 (13) |
| At least 2 diagnoses | 5 (31) | 2 (14) | 7 (23) |
| No concomitant disease | 1 (6) | 1 (7) | 2 (7) |